Initial Detection of Prostate Cancer in Several Centers In Santo Domingo, Dominican Republic.
DOI:
https://doi.org/10.54212/27068048.v8i2.37Keywords:
Cancer, Prostate, Presentation, DominicanAbstract
OBJECTIVE: Determine the initial stage of presentation of prostate cancer in patients attending the urology clinic.
MATERIAL AND METHODS: The electronic records of a total of 2,770 male patients between 40 and 95 years old who were consulted for the first time in the urology service from 2016 to August 2020 and were retrospectively analyzed. 130 patients met the inclusion criteria: age between 40 and 95 years, prostate specific antigen (PSA) above 4 ng / dl., diagnosis of prostate cancer by biopsy or immunohistochemistry, extension studies such as bone scintigraphy and contrast abdominal and pelvic tomography. All prostate cancer follow-up patients were excluded.
RESULTS: The most frequent age range in which the initial detection of prostate cancer occurred was 71 to 80 years for 67.6%, followed by 61 to 70 years (42%). 58.5% of the patients had PSA between 4 to 10 ng / dl, for 58.5%. The most predominant Gleason was Gleason 6 (3 + 3), 53.3%. In 41.6% of the cases it was low risk. 41 (31.5%) of the 130 patients with prostate cancer diagnosed with histopathological study were positive for bone metastases by bone scintigraphy. 25 patients presented visceral metastases on abdominal tomography.
CONCLUSION: These results provide information that contributes to enriching the deficient registry of urological tumors in our region.
Downloads
References
Ramos Christian, Fulla O. Juan, Mercado C. Alejandro. Detección precoz del cáncer de prostata, controversias y recomendaciones actuales. Rev. Med.Clín. Condes. Elsevier. 2018. 29 (2): 128-135. https://doi.org/10.1016/j.rmclc.2018.02.013 DOI: https://doi.org/10.1016/j.rmclc.2018.02.013
Organización Mundial de la Salud. Control del cancer, aplicación para los conocimientos. Guia de la OMS para desarrollo de programas eficaces. 2007. Modulo III. 29-36.
American Society of Clinical Oncology. ASCO. Cáncer de prostata estadios y grados. 2018 marzo.
American Cancer Society: Cancer de Próstata. 2019. 1 agosto.
González Aranzazu del Alba, Lázaro Quintela Martin. Cancer de próstata. SEOM. 2017 6 marzo: 1-11.
Asociación Europea de Urología. Cáncer de próstata 2020.
American Urological Asociation. Diagnostic accuracy of targeted prostate cancer biopsies comparing micro ultrasound with MRI for detección of prostate cancer. 2019. Nov.
Mariela Paw-Sang, Victor Destefano, Juan Carlos Astigueta, Octavio Catillo, Juan Luis Gaona, Felix Santaella, et al. Cáncer de próstata en latiniamerica. Actas urol. Esp. Elsevier. 2009. 1 nov. 33(10): 1057-1061. https://doi.org/10.1016/S0210-4806(09)73181-X DOI: https://doi.org/10.1016/S0210-4806(09)73181-X
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 David Enrique Soriano Morillo, Merycarla Pichardo García, Loribel Martínez, Marlin Fernandez, Cristian Alberto González Santana
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
